Skip to main content

Life Sciences

In the sector’s constantly evolving landscape, life sciences companies often need to address uncertainties while bringing new discoveries and innovative solutions to life. Deloitte's customized solutions can help clients uncover their potential and drive progress towards the Future of Health™.

Together, advancing the business of science

Across life sciences you’ll find innovators who are developing therapies, treatments, devices, and cures to meet society’s most pressing health challenges and deliver wellness for all. Alongside them, you’ll find our leaders, the professionals of Deloitte member firms’ Life Sciences practices, who are orchestrating and delivering the business of science and health. We help drive impact through deep industry experience and insights; transformative strategies; trusted, flexible approaches; and new technologies. We help accelerate action and create connections that empower a digitally enabled future of health.

Our thinking

Beyond borders: Japanese life sciences organizations evolving for global growth

Driven by domestic economic and industry-specific challenges, many Japan-headquartered life sciences organizations are looking at greater globalization as a catalyst for growth and innovation. This report highlights this trend via executive interviews across Japanese life sciences (LS) organizations, non-Japanese LS organizations, and cross-industry Japanese organizations.
Perspective
10 minute read

Measuring the return from pharmaceutical innovation

Our 15th year analysing the forecast average  internal rate of return (IRR) for the top 20 biopharma companies, reveals a second year of growth  to 5.9 per cent in 2024. Discover more.
Research
5 minute read

2025 life sciences outlook

Despite industry uncertainties, life sciences execs expect their organizations to adapt, grow, and generate value

Life Sciences and Healthcare Predictions 2030

Life Sciences and Healthcare Predictions 2030 
Collection

Pharma’s supply chain workforce

Biopharma's early digitization efforts showcase the need to adopt a more comprehensive development strategy for the supply chain workforce and other functions.

Women’s health investment trends

Deloitte’s analysis of health tech investment trends reveals an increased focus on women's health, but challenges remain.

Medtech’s digital innovation era

Deloitte survey findings reveal how medtech companies are using (and not using) digital technologies to transform their businesses.

Biopharma’s digital supply chain

Investments in end-to-end digitalization can overhaul the industry’s supply chain processes while keeping patients’ best interests at the fore and the competition at bay.

Unleash AI’s potential

Measuring the return from pharmaceutical innovation – 14th edition

Connect with our Life Sciences team

Vicky Levy

Vicky Levy

Deloitte Global Life Sciences & Health Care Industry Leader
+1 617 437 3325
Todd Konersmann

Todd Konersmann

Deloitte Global Life Sciences Sector Leader
+1 214 840 1993

Deloitte Insights

Explore the magazine

Get ahead of the today’s most pressing business challenges

Read the latest issue

Get the app

Receive personalized insights on the topics that matter most to you 

Download the free app

Stay up to date

Don’t miss our most current and most popular data, research, and analysis

Browse our insights

Explore more industry thinking

Health Care

By focusing on health care necessities and demands, our thought leadership and experience can help shift market paradigms. With Deloitte’s Health Equity and Future of Health™ thinking, we provide perspectives and innovative approaches to reshape the future of health care.
Find out more